Erasmus MC researchers found a way to reduce immunotherapy side effects without affecting cancer killing.
Public source
Publisher name
Public post
Onderzoekers van het Erasmus MC hebben misschien een manier gevonden om de bijwerkingen van immunotherapie te verminderen, zonder de werking tegen kanker te beïnvloeden.…
Company
Erasmus MC
Voor een gezonde toekomst
- Industry
- Hospitals and Health Care
- Location
- Rotterdam, NL
- Company size
- 10,001+ employees
About Erasmus MC
We are Erasmus MC. Our roots lie in Rotterdam, a city and port of international standing. We are the most innovative university medical center in the Netherlands and one of the world’s leading centers of scientific research. We are committed to achieving a healthy population and pursuing excellence in healthcare through research and teaching. Day in, day out, our staff, volunteers and students work with passion and dedication to achieve everything we stand for: safe, first-rate healthcare for patients with complex issues, unusual and rare conditions or acute needs. But we also stand for top-quality teaching that attracts ambitious, inquisitive and talented students and seeks to answer the healthcare questions of tomorrow. And we stand for world-class scientific research that bolsters our understanding of diseases and disorders and helps to predict, treat and prevent them. We do our work based on our basic principles, the core values of Erasmus MC, 'responsible', 'connecting' and 'enterprising'. We believe that we provide the best care, research and education if we are responsible, binding and enterprising.
See moreLatest activity
Latest activity from Erasmus MC
10 signals
People
Erasmus MC has appointed Universitair Hoofddocent (UHD) Dr. Suzanne Peeters and Dr. Gijs Elshout to teach in the medical center.
People
Erasmus MC hired Arjan as an apothekersassistent.
Research & Knowledge
Erasmus MC welcomed Cindy Steward to its neuroscience research program, where she graduated from her Research MSc in Neuroscience.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
IKNL (Integraal Kankercentrum Nederland)
IKNL (Integraal Kankercentrum Nederland) published a research paper titled Introducing Real-World Data and Multi-state Modeling in Clinical Trials in Acute Leukemia - Benefits and Risks in the journal Oncology.
Research & Knowledge
Prinses Máxima Centrum voor kinderoncologie
Prinses Máxima Centrum voor kinderoncologie reports that 83% of children with cancer are alive ten jaar na their diagnosis, up from 77% in the previous year.
Research & Knowledge
Amsterdam UMC
Amsterdam UMC published a new national control schema for patients with cancer and a low risk of recurrence, replacing four CT scans with two in two years and two in five years.
Research & Knowledge
Amsterdam UMC - Cancer Center Amsterdam
Amsterdam UMC - Cancer Center Amsterdam published a new series of research videos asking researchers five questions about their work and what their research could mean for patients.
Research & Knowledge
Nederlandse Federatie van Kankerpatiëntenorganisaties (NFK)